Pharma moved away from engaging employers in a meaningful way over the past decade for a variety of reasons. This resulted in a lack of employer education. For some brands this is beginning to become a recognized barrier to market access.
Dave Dierk and Stacey Richter, co-presidents of Aventria Health Group, share their insights on this emerging market dynamic in a December 2019 article in Pharmaceutical Executive, Market Access: Employers as Barriers to Value.
“You’re starting to see Pharma, once again, increase its field team presence calling on employers, because the employers are beginning to take back control.”
Now innovative pharma teams are looking to foster new relationships with employers and their advisors as they take back control of decision making over their health care spend.
Dierk discusses some areas where Pharma is likely to build field forces and which employers Pharma should consider targeting if they’re trying to maintain access for large, high-cost, high-need, chronic patients.
She and Dierk discuss the most important success factors for Pharma to consider when collaborating with employers.
More employer insights: Employer Influence in Oncology
For information about how Aventria Health Group can help you achieve market-access success, please reach out to:
Dave Dierk, Co-President, 30-year sales and marketing thought leader in pharmaceutical diagnostics, biomedical, long-term care, managed care, employer, and pharmacy communications, at 215-489-9000 x103 or email@example.com.
Stacey Richter, Co-President, 20-year market-access innovator specializing in niche market engagement, raising above-brand performance and HIT-integrated programs, at 978-705-1137 x105 or firstname.lastname@example.org.
Making a difference in patient care by helping patients, providers, and payers collaborate on shared priorities